We observed nine cases of transitional-cell carcinoma of the urinary bladder among patients who had had long-term treatment of other cancers with cyclophosphamide. Seven of the bladder carcinomas occurred within a cohort of 471 patients treated for non-Hodgkin's lymphomas. In this cohort the relative risk of bladder cancer was 6.8 (95 percent confidence interval, 3.2 to 14.2). The cumulative risk (mean +/- SE) was 3.5 +/- 1.8 percent 8 years after the start of treatment with cyclophosphamide and 10.7 +/- 4.9 percent after 12 years. Three of the nine patients were 50 years of age or younger; seven died with progressive bladder cancer. Subsequently, an additional patient had acute nonlymphocytic leukemia. Hemorrhagic cystitis was observed in 33 patients (cumulative risk, 11.8 +/- 2.1 percent after five years). Development of carcinoma of the urinary bladder was not related to previous hemorrhagic cystitis. The results caution against long-term treatment with cyclophosphamide for diseases with a favorable prognosis.
Source Information
Department of Internal Medicine and Hematology, Finsen Institute-Rigshospitalet, Copenhagen, Denmark.
This article has been cited by other articles:
Maule, M., Scelo, G., Pastore, G., Brennan, P., Hemminki, K., Tracey, E., Sankila, R., Weiderpass, E., Olsen, J. H., McBride, M. L., Brewster, D. H., Pompe-Kirn, V., Kliewer, E. V., Chia, K. S., Tonita, J. M., Martos, C., Jonasson, J. G., Merletti, F., Boffetta, P.
(2007). Risk of Second Malignant Neoplasms After Childhood Leukemia and Lymphoma: An International Study. JNCI J Natl Cancer Inst
99: 790-800
[Abstract][Full Text]
Mudie, N. Y., Swerdlow, A. J., Higgins, C. D., Smith, P., Qiao, Z., Hancock, B. W., Hoskin, P. J., Linch, D. C.
(2006). Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort Study. JCO
24: 1568-1574
[Abstract][Full Text]
Knight, A, Askling, J, Granath, F, Sparen, P, Ekbom, A
(2004). Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide. Ann Rheum Dis
63: 1307-1311
[Abstract][Full Text]
Oeffinger, K. C., Hudson, M. M.
(2004). Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors. CA Cancer J Clin
54: 208-236
[Abstract][Full Text]
Peterson, B. A., Petroni, G. R., Frizzera, G., Barcos, M., Bloomfield, C. D., Nissen, N. I., Hurd, D. D., Henderson, E. S., Sartiano, G. P., Johnson, J. L., Holland, J. F., Gottlieb, A. J.
(2003). Prolonged Single-Agent Versus Combination Chemotherapy in Indolent Follicular Lymphomas: A Study of the Cancer and Leukemia Group B. JCO
21: 5-15
[Abstract][Full Text]
Van den Berg-Vos, R. M., Franssen, H., Wokke, J. H. J., Berg, L. H. V. d.
(2002). Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment. Brain
125: 1875-1886
[Abstract][Full Text]
Davis, L. E.
(1991). Long-Term Complications of Antineoplastic Agents. Journal of Pharmacy Practice
4: 131-150
Previous
